Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma (Q38770935)

6 September 2017

Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma (English)

1 reference

6 September 2017

Jian Zhou

1

1 reference

PubMed ID

26969471

6 September 2017

Ao Huang

series ordinal

2

1 reference

PubMed ID

26969471

6 September 2017

Xin-Rong Yang

series ordinal

3

1 reference

6 September 2017

11 March 2016

1 reference

Journal of gastrointestinal cancer

6 September 2017

1 reference

6 September 2017

47

1 reference

6 September 2017

157-167

1 reference

6 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s12029-016-9801-0

6 September 2017

0 references

cites work

Liquid biopsy: monitoring cancer-genetics in the blood

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Mutational landscape and clonal architecture in grade II and III gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Intratumor heterogeneity in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Translational implications of tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

The biology of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells: a multifunctional biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Molecular profiling of single circulating tumor cells with diagnostic intention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Assessment of DNA Integrity, Applications for Cancer Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor DNA moves further into the spotlight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Going with the flow: from circulating tumor cells to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor DNA as a liquid biopsy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Clinical outcome prediction by microRNAs in human cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Exosomal microRNA: a diagnostic marker for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Detection and Characterization of Circulating Tumor Cells by the CellSearch Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Molecular analysis of circulating tumour cells-biology and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Isolation and retrieval of circulating tumor cells using centrifugal forces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

A microfluidic device for label-free, physical capture of circulating tumor cell clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Current State of Circulating MicroRNAs as Cancer Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Analysis of circulating microRNA: preanalytical and analytical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating cell free DNA: Preanalytical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Computational optimisation of targeted DNA sequencing for cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Digital PCR analysis of circulating nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Considerations for digital PCR as an accurate molecular diagnostic tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

MicroRNAs as promising biomarkers in cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Novel plasma microRNA biomarkers for the identification of colitis-associated carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Monitoring gastric cancer progression with circulating tumour DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Screening for epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Beyond counting: new way to use circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Retracted: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Plasma microRNA, a potential biomarker for acute rejection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Factors influencing circulating MicroRNA level in the studies of hepatocellular carcinoma biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Diagnosis by extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-016-9801-0

Relation between serum levels of cell-free DNA and inflammation status in hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness

1 reference

12 December 2020

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

1 reference

12 December 2020

Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform

1 reference

12 December 2020

Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma

1 reference

12 December 2020

Identification of prostate cancer biomarkers in urinary exosomes

1 reference

12 December 2020

Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients

1 reference

12 December 2020

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

12 December 2020

Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients

1 reference

12 December 2020

Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma

1 reference

12 December 2020

Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker

1 reference

12 December 2020

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

1 reference

12 December 2020

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.

1 reference

12 December 2020

Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.

1 reference

12 December 2020

Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

1 reference

12 December 2020

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma

1 reference

12 December 2020

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

1 reference

12 December 2020

Quantitation of targets for PCR by use of limiting dilution

1 reference

12 December 2020

The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma

1 reference

12 December 2020

Next-generation sequencing in precision oncology: challenges and opportunities

1 reference

12 December 2020

Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients

1 reference

12 December 2020

Circulating plasma microRNAs as a screening method for detection of colorectal adenomas

1 reference

12 December 2020

Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation

1 reference

12 December 2020

Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma

1 reference

12 December 2020

MicroRNA biomarkers in whole blood for detection of pancreatic cancer

1 reference

12 December 2020

10.1007/S12029-016-9801-0

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

26969471